Higher cumulative fluid balance in ICU patients with sepsis tied to major adverse kidney events
Recent research found that Patients admitted to ICU due to sepsis and with higher cumulative fluid balance for 2 days subsequently developed major Adverse kidney events within 30 days. The study was published in 'Annals of Intensive Care.'
The mainstay of treatment for hemodynamic instability during the early phase of sepsis is Fluid resuscitation. But conventional fluid resuscitation along with other maintenance fluids may lead to fluid accumulation which can lead to major adverse kidney events within 30 days (MAKE30). So, researchers from Sweden ad Italy conducted a study to find the association between cumulative fluid balance and major adverse kidney events within 30 days (MAKE30), a composite of death, dialysis, or sustained renal dysfunction, in such patients.
Researchers conducted a multicenter, retrospective observational study on 1834 septic patients admitted to five ICUs in three hospitals in Stockholm, Sweden. To assess the association between cumulative fluid balance during the first two days in ICU and subsequent risk of MAKE30, adjusted for demographic factors, comorbidities, baseline creatinine, illness severity variables, hemodynamic characteristics, chloride exposure, and nephrotoxic drug exposure logistic regression analysis was used. The strength of significant exposure variables using a relative importance analysis was also assessed.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.